08.03.2016 - UK-Swedish drugs maker AstraZeneca has agreed to sell the European rights for Moventig to ProStrakan, a subsidiary of Japanese life sciences company Kyowa Hakko Kirin. The drug is...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)
